SENS
The Newsroom
In The Media
Media Contacts
Leadership & Structure
Corporate Governance
Our Heritage
Diversity
Learning & Development
Strategic Alliances
Anti-retroviral Portfolio (ARVs)
Generics
Optimise Your Health
Addiction Awareness
Self Medication
Medical Tips
Medicine Safety
Package Inserts
Any Queries? Contact Us
Brand News
Brands At A Glance
Our Commitment
Single Exit Price
The Investment Case
Financial Reports
Financial Indicators
Shareholder Corner
Contact Investor Relations
SENS
Passion For Our
Community
Our Latest Initiatives
The Environment
Require Funding?
Contact Us
Careers At Adcock Ingram
Latest Opportunities
Thank you for accessing Adcock Ingram's corporate website. Our website offers a diverse range of information about our Company to help give you an understanding of who we are and what we have to offer.
Please
contact us
should you require any further information.
Jonathan Louw (CEO Adcock Ingram)
Group Audited Results 2011
Group Audited Results 2011
Results Presentation 2011
Webcast
Pharmaceutical industry leader Adcock Ingram welcomes the recent joint announcement made by the Department of Trade and Industry and Department of Health...
[READ MORE]
20
May
Sunday
Su
Mo
Tu
We
Th
Fr
Sa
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
Latest Share Price
N/A cents
Percentage Change:
0.00
Code:
AIP
PE Ratio:
13.61
EY:
7.35
DY:
2.96
ZAR/USD:
8.3411
Interim Dividend
(cents):
106.00
Final Dividend
(cents):
81.00